Table 2.
The influence of prebiotics, probiotics, and postbiotics on metabolic syndrome
|
Category
|
Influence
|
|
|
| Prebiotic | Inulin | Decrease Firmicutes to Bacteroidetes ratio[22] | Improvement in Obesity |
| Fructooligosaccharides | Increase Bifidobacterium[26] | Promotes gut health | |
| Decrease expression of inflammatory cytokines | |||
| Improved Insulin sensitivity | |||
| Galactooligosaccharides | Increase Akkermansia mucinophila. Increase in Prevotella[27] | Intestinal barrier protection | |
| Improved Insulin sensitivity | |||
| Decrease inflammation | |||
| Probiotic | Bifidobacterium | Increasing Akkermansia mucinophila[56] | Intestinal barrier protection |
| Improved Insulin sensitivity | |||
| Decrease inflammation | |||
| Lactobacillus | Decreasing Firmicutes to Bacteroidetes ratio[57] | Improvement in Obesity | |
| Postbiotic | Heat-killed Akkermansia mucinophila | Improves metabolic state in Obesity | |
| Heat-inactivated Lactobacillus paracasei | Reduces the risk of pharyngitis, laryngitis, and diarrhea | ||
| Heat-inactivated Bifidobacterium bifidum | Reduces symptoms of irritable bowel syndrome | ||
| Butyrate (SCFA produced by the inactive microbe) | Increasing Lachnospiraceae[46] | Protection against diabetes and cardio-vascular diseases | |
| Increasing Proteobacteria[46] | Increased gut mucus production | ||
| Decreasing Clostridiaceae[46] | Increased gut barrier integrity | ||
SCFAs: Short Chain Fatty Acids.